Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Piper Sandler Downgrades Virtus Investment to Neutral

Piper Sandler Downgrades Virtus Investment to Neutral

Piper Sandler analyst Sumeet Mody downgrades Virtus Investment (NASDAQ:VRTS) from Overweight to Neutral.

byBenzinga Newsdesk

February 6, 2023

1 minute read

Piper Sandler analyst Sumeet Mody downgrades Virtus Investment (NASDAQ:VRTS) from Overweight to Neutral.

News

Creatd Ventures Sees Amazon Sales Increasing Across Its Portfolio Of CPG Brands

By Benzinga Newsdesk

August 25, 12:20 PM

Creatd, Inc. (Nasdaq CM: CRTD) ("Creatd" or the "Company"), is pleased to provide an update on Creatd Ventures' portfolio of consumer product goods brands.

AMZN

UBS Maintains Neutral on Carter’s, Lowers Price Target to $72

By Benzinga Newsdesk

July 15, 10:05 AM

UBS analyst Jay Sole maintains Carter's (NYSE:CRI) with a Neutral and lowers the price target from $100 to $72.

CRI

Wells Fargo Maintains Underweight on Bio-Techne, Lowers Price Target to $360

By Benzinga Newsdesk

August 16, 7:38 AM

Wells Fargo analyst Timothy Daley maintains Bio-Techne (NASDAQ:TECH) with a Underweight and lowers the price target from $370 to $360.

TECH

Analyst Ratings

Analyst Expectations for Conagra Brands’s Future

By Benzinga Insights

October 9, 9:00 AM

Analysts have provided the following ratings for Conagra Brands (NYSE:CAG) within the last quarter: Bullish Somewhat Bullish Indifferent…

CAG

Piper Sandler Downgrades Virtus Investment to Neutral

Related Posts

Creatd Ventures Sees Amazon Sales Increasing Across Its Portfolio Of CPG Brands

UBS Maintains Neutral on Carter’s, Lowers Price Target to $72

Wells Fargo Maintains Underweight on Bio-Techne, Lowers Price Target to $360

Analyst Expectations for Conagra Brands’s Future